Volume 4, Issue 3 (Autumn 2001)
J Arak Uni Med Sci 2001, 4(3): 32-35 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ayatolahi J. A Clinical Trial on Combination of Metronidazole and Iodoquinol Tablets One Week Duration in the Treatment of Acute Amebiasis. J Arak Uni Med Sci 2001; 4 (3) :32-35
URL: http://jams.arakmu.ac.ir/article-1-6734-en.html
URL: http://jams.arakmu.ac.ir/article-1-6734-en.html
Faculty Member OF Medicine ,Yazd University of Medical Sciences, Yazd, Iran.
Abstract: (2911 Views)
Introduction: Amebiasis, Caused by Entamoeba histolytica. Is one of the three most common prevalent parasites that causes mortality.
Material and Method: This clinical trial was carried out among 45 patients suffering from acute enteric amebiasis. Each patient receives 750 mg metronidazole and 630 mg iodoquinol every eight hours for one week, the following results were obtained.
Results: All of the patients were completely treated at the end of two weeks and did not have any sign of the diseases. Also two weeks after cessation of therapy, stool test for entamobea histolytica (cyst and trophozoite) was negative in all of patients.
Conclusion: It seems by further research, we can decrease does of medications and duration treatment in these patients.
Material and Method: This clinical trial was carried out among 45 patients suffering from acute enteric amebiasis. Each patient receives 750 mg metronidazole and 630 mg iodoquinol every eight hours for one week, the following results were obtained.
Results: All of the patients were completely treated at the end of two weeks and did not have any sign of the diseases. Also two weeks after cessation of therapy, stool test for entamobea histolytica (cyst and trophozoite) was negative in all of patients.
Conclusion: It seems by further research, we can decrease does of medications and duration treatment in these patients.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
